Physician profile
Amy E Lucius
NPI 1548600653
$747.33
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $105 · 2023: $200 · 2024: $140 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $299.71 | 2022-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Anastoclip Gc 8cm (Medium) |
| Abbott Laboratories | $141.01 | 2021 | |
| Medtronic, INC. | $60.67 | 2023 | Endurant Iis |
| Surgenex LLC | $53.14 | 2025 | Renograft, Ardeograft, Surgraft |
| Baxter Healthcare | $41.45 | 2025 | Perclot |
| Ethicon US, LLC | $26.10 | 2023 | Harmonic, Ethicon, Prolene |
| Surmodics, INC. | $23.33 | 2023 | Pounce Thrombectomy System, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Solventum Corporation | $21.16 | 2025 | V.A.C.Ulta, Prevena |
| Hydrofera LLC | $19.34 | 2023 | Hydrofera Blue |
| Acera Surgical, INC. | $18.15 | 2023 | Restrata Wound Matrix |
| W. L. Gore & Associates, INC. | $15.95 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Janssen Pharmaceuticals, INC | $15.81 | 2022 | |
| Boston Scientific Corporation | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lucius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.